KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 72 filers reported holding KRONOS BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,278,568 | -24.4% | 1,752,745 | 0.0% | 0.08% | -12.6% |
| Q2 2023 | $3,014,721 | +17.8% | 1,752,745 | 0.0% | 0.09% | +14.5% |
| Q1 2023 | $2,558,131 | -9.9% | 1,752,745 | 0.0% | 0.08% | -5.0% |
| Q4 2022 | $2,839,446 | -60.7% | 1,752,745 | -18.7% | 0.08% | -61.9% |
| Q3 2022 | $7,223,000 | -18.0% | 2,156,151 | -10.9% | 0.21% | -23.9% |
| Q2 2022 | $8,812,000 | -49.7% | 2,421,142 | 0.0% | 0.28% | -21.4% |
| Q1 2022 | $17,504,000 | -73.4% | 2,421,142 | -50.0% | 0.35% | -30.9% |
| Q4 2021 | $65,806,000 | +29.7% | 4,842,284 | +100.0% | 0.51% | -31.1% |
| Q3 2021 | $50,747,000 | -58.1% | 2,421,142 | -52.1% | 0.74% | -6.2% |
| Q2 2021 | $121,094,000 | +52.0% | 5,056,104 | +81.9% | 0.79% | -22.0% |
| Q1 2021 | $79,671,000 | -4.1% | 2,780,097 | 0.0% | 1.01% | +13.1% |
| Q4 2020 | $83,041,000 | – | 2,780,097 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $57,961,000 | 16.60% |
| Omega Fund Management, LLC | 3,818,283 | $80,031,000 | 8.98% |
| Wildcat Capital Management, LLC | 1,438,232 | $30,145,000 | 3.90% |
| COMMODORE CAPITAL LP | 298,839 | $6,264,000 | 1.65% |
| Perceptive Advisors | 2,421,142 | $50,747,000 | 0.74% |
| Alphabet Inc. | 1,438,232 | $30,145,000 | 0.72% |
| Artal Group S.A. | 1,317,954 | $27,624,000 | 0.62% |
| Choate Investment Advisors | 393,436 | $8,246,000 | 0.53% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 527,500 | $11,056,000 | 0.51% |
| Coastal Bridge Advisors, LLC | 78,635 | $1,648,000 | 0.38% |